Identification of plasma protein profiles associated with risk groups of prostate cancer patients.

Summary, in English

Early detection of prostate cancer (PC) using prostate-specific antigen (PSA) in blood reduces PC-death among unscreened men. However, due to modest specificity of PSA at commonly used cut-offs, there are urgent needs for additional biomarkers contributing enhanced risk classification among men with modestly elevated PSA.

• Författare: Malin Nordström; Christer Wingren; Carsten Rose; Anders Bjartell; Charlotte Becker; Hans Lilja; Carl A K Borrebaeck
• Avdelning/ar: Klinisk kemi, Malmö; Avdelningen för translationell cancerforskning; Bröstcancer-genetik; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation; Urologisk cancerforskning, Malmö; EpiHealth: Epidemiology for Health
• Publiceringsår: 2014
• Språk: Engelska
• Sidor: 951-962
• Publikation/Tidskrift/Serie: Proteomics Clinical Applications
• Volym: 8
• Issue: 11-12
• Fulltext: - 5 kB; Download statistics
• Länkar: http://www.ncbi.nlm.nih.gov/pubmed/25196118?dopt=Abstract; http://dx.doi.org/10.1002/prca.201300059
• Dokumenttyp: Artikel i tidskrift
• Förlag: John Wiley & Sons Inc.
• Ämne: Cell and Molecular Biology
• Status: Published
• Forskningsgrupp: Clinical Chemistry, Malmö; Urological cancer, Malmö
• ISBN/ISSN/Övrigt: ISSN: 1862-8354